Related Experiment Video
Updated: May 22, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
[On the history of heart failure]
1Universitätsklinikum Bonn, Sigmund-Freud-Strasse 25, Bonn, Germany. b.luederitz@uni-bonn.de
Insights
Heart failure, characterized by left-ventricular dysfunction, has a poor prognosis. Treatments evolved from bloodletting and digitalis to modern therapies like ACE inhibitors, beta-blockers, and emerging stem cell technology.
Area of Science:
- Cardiology
- Medical History
Context:
- Left-ventricular dysfunction, a form of heart muscle pump weakness, is a cardiac disease with increasing prevalence and incidence.
- Historically, treatments for cardiac illnesses ranged from bloodletting to herbal remedies.
Purpose:
- To provide a historical overview of cardiac disease treatment.
- To highlight the evolution of pharmacological and technological interventions for heart failure.
Summary:
- Digitalis, derived from foxglove, was an early significant cardiac drug.
- The 1980s saw the introduction of vasodilators and inotropic drugs, followed by ACE inhibitors and beta-receptor blockers in the 1990s.
- Recent advancements include cardiac resynchronization therapy (CRT), left-heart assist systems, and experimental cellular/genetic approaches, including stem cell technology and xenotransplants.
Impact:
- Understanding the historical progression of cardiac treatments informs current therapeutic strategies.
- The development of new therapies has improved management of heart failure, though challenges remain.
- Emerging technologies like stem cells offer future potential but require further clinical validation.
Abstract:
The heart is by far the organ that is best known and has been identified for a long time. Myogenic weakness of the heart muscle pump with left-ventricular dysfunction remains the cardiac disease with the poorest prognosis while increasing in prevalence and incidence. Aside from all sorts of mystic treatment attempts and dubious herbal medicine, bloodletting was established early on as a superior remedy, which was applied in response to almost all cardiac illnesses. The first and perhaps most important cardiac drug was digitalis, the glycoside of the red and even more so of the white foxglove, described in 1552 by Leonhart Fuchs. In the 1980s, vasodilators and inotropic drugs supplemented the classical medications digitalis and diuretics. ACE inhibitors and beta-receptor blockers were added in the 1990s; at the turn of the millennium, the cardiac resynchronization therapy (CRT) and left-heart assist systems were developed; lately, there have been cellular and genetic approaches as well as xenotransplants. Preliminary results with stem cell technology are encouraging; however, it will be years until a clinical application-if it will happen at all.
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Heart Failure III: Clinical Manifestations